Evidence map›Paper›PMID 40445546›Full record

ArticleBulletin of experimental biology and medicine2025

Clonogenic Capacity and Migration Potential of A549 and HeLa Cell Lines Survived after Acute X-Ray Irradiation at a Dose of 15 Gy.

A A Tsishnatti, S M Rodneva, Yu A Fedotov, V D Gurev, V N Belyaev, D V Guryev

Abstract read
PubMed Publisher
In one paragraph

Article in Bulletin of experimental biology and medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Fractionation-Based Modeling of Hawthorn (Molecules (Basel, Switzerland) · 2026
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

A A TsishnattiBurnasyan Federal Medical Biophysical Center, Federal Medical Biology Agency of Russia, Moscow, Russia.
S M RodnevaBurnasyan Federal Medical Biophysical Center, Federal Medical Biology Agency of Russia, Moscow, Russia.
Yu A FedotovBurnasyan Federal Medical Biophysical Center, Federal Medical Biology Agency of Russia, Moscow, Russia.
V D GurevBurnasyan Federal Medical Biophysical Center, Federal Medical Biology Agency of Russia, Moscow, Russia.
V N BelyaevNational Research Nuclear University (MEPHI), Moscow, Russia.
D V GuryevBurnasyan Federal Medical Biophysical Center, Federal Medical Biology Agency of Russia, Moscow, Russia. Denis.Guryev@gmail.com.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We obtained A549 and HeLa cell lines that survived and showed stable growth after acute X-ray irradiation at a dose of 15 Gy (hereinafter referred to as A549RR and HeLaRR). Comparative studies of the proliferative activity of original (A549, HeLa) and survived (A549RR, HeLaRR) cells and their sensitivity to additional X-ray irradiation at doses of 2, 4, and 6 Gy by the clonogenic capacity and migration potential (scratch-wound test) were carried out. It was found that the doubling time of the cell population for the A549RR and HeLaRR lines was significantly lower than for the original non-irradiated cells without additional exposure. A549RR and HeLaRR cell lines demonstrated higher resistance to additional X-ray irradiation in terms of clonogenic ability. Migration potential, as one of the critical processes during tumor metastasis, appeared to be significantly higher for A549RR cells up to 24 h after irradiation at a dose of 2 Gy and up to 48 h after irradiation at a dose of 4 Gy. Migration of HeLaRR cells was significantly higher without additional exposure and after irradiation at doses of 2 and 4 Gy, while after irradiation at a dose of 6 Gy, migration activity of HeLaRR cells was significantly suppressed compared to original cells.

Indexed as

Cell MovementA549 CellsCell ProliferationCell SurvivalDose-Response Relationship, RadiationHeLa CellsHumansRadiation ToleranceX-RaysA549clonogenic assayHeLaradioresistancescratch-wound test

Identifiers

PMID40445546

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.